Cargando…

Frequency and Associations of Adverse Reactions of COVID-19 Vaccines Reported to Pharmacovigilance Systems in the European Union and the United States

INTRODUCTION: This study aims to provide a risk assessment of the adverse reactions related to the COVID-19 vaccines manufactured by AstraZeneca, Janssen, Moderna, and Pfizer-BioNTech which have been in use in the European Union and the United States between December 2020 and October 2021. METHODS:...

Descripción completa

Detalles Bibliográficos
Autor principal:	Montano, Diego
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850379/ https://www.ncbi.nlm.nih.gov/pubmed/35186864 http://dx.doi.org/10.3389/fpubh.2021.756633

Ejemplares similares

Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
por: Shu, Yamin, et al.
Publicado: (2022)

Transparency in Negotiation of European Union With Big Pharma on COVID-19 Vaccines
por: Sciacchitano, Salvatore, et al.
Publicado: (2021)

Comparing pharmaceutical pricing and reimbursement policies in Croatia to the European Union Member States
por: Vogler, Sabine, et al.
Publicado: (2011)

Sustainable Health and Wellbeing in the European Union
por: Gavurova, Beata, et al.
Publicado: (2022)

Citizen engagement initiatives in precision health in the European Union member states: a scoping review
por: Pezzullo, Angelo Maria, et al.
Publicado: (2021)

Greenhouse Gas Emissions and Health in the Countries of the European Union
por: Gavurova, Beata, et al.
Publicado: (2021)

COVID-19 Vaccines Adverse Reactions Reported to the Pharmacovigilance Unit of Beira Interior in Portugal
por: Amaro, Carina, et al.
Publicado: (2022)

Causes and circumstances of accidents at work in the European Union, Slovakia and Czech Republic
por: Hollá, Katarína, et al.
Publicado: (2023)

A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults
por: Cappelletti-Montano, Beniamino, et al.
Publicado: (2023)

Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on
por: Mangat, Halinder S., et al.
Publicado: (2022)

Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works
por: Santoro, Aniello, et al.
Publicado: (2017)

Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia’s spontaneous vaccine pharmacovigilance system, 2016–2020
por: Li-Kim-Moy, Jean, et al.
Publicado: (2023)

Highly varying concepts and capacities of forensic mental health services across the European Union
por: Salize, Hans Joachim, et al.
Publicado: (2023)

Status and contents of physical activity recommendations in European Union countries: a systematic comparative analysis
por: Gelius, Peter, et al.
Publicado: (2020)

How the European Union legislations are tackling the burden of diabetes mellitus: A legal surveillance study
por: Mahrouseh, Nour, et al.
Publicado: (2022)

Methodological approaches for medication error analyses in patient safety and pharmacovigilance reporting systems: a scoping review protocol
por: Tchijevitch, Olga, et al.
Publicado: (2022)

Psychiatric adverse events reported after COVID-19 vaccination in the European Union (EU), the United States (US) and the United Kingdom (UK)
por: Macias Saint-Gerons, D., et al.
Publicado: (2022)

European Union Structural Funds as the Source of Financing Health Care Infrastructure Investments in Poland—A Longitudinal Analysis
por: Dubas-Jakóbczyk, Katarzyna, et al.
Publicado: (2022)

Protecting public health and the environment: towards a general ban on cellulose acetate cigarette filters in the European Union
por: Everaert, Stijn, et al.
Publicado: (2023)

The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS)
por: Geier, David A., et al.
Publicado: (2012)

Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review
por: Menang, Olga, et al.
Publicado: (2023)

Quality of Spontaneous Reports of Adverse Drug Reactions Sent to a Regional Pharmacovigilance Unit
por: Salvador, Mário Rui, et al.
Publicado: (2022)

Disparities in case frequency and mortality of coronavirus disease 2019 (COVID-19) among various states in the United States
por: Loomba, Rohit S., et al.
Publicado: (2020)

First cross-border outbreak of foodborne botulism in the European Union associated with the consumption of commercial dried roach (Rutilus rutilus)
por: Hendrickx, David, et al.
Publicado: (2023)

The European Union and Public Health Emergencies: Expert Opinions on the Management of the First Wave of the COVID-19 Pandemic and Suggestions for Future Emergencies
por: Gontariuk, Marie, et al.
Publicado: (2021)

Burden of All Cancers Along With Attributable Risk Factors in China From 1990 to 2019: Comparison With Japan, European Union, and USA
por: Yang, Xiaorong, et al.
Publicado: (2022)

Population health differences in cross-border regions within the European Union and Schengen area: a protocol for a scoping review
por: Stroisch, Sophie, et al.
Publicado: (2023)

COVID-19 Vaccine Hesitancy in the United States: A Systematic Review
por: Yasmin, Farah, et al.
Publicado: (2021)

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
por: Hadi, Muhammad Abdul, et al.
Publicado: (2017)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

The History of Anthrax Weaponization in the Soviet Union
por: Nikolakakis, Ioannis, et al.
Publicado: (2023)

Report on the state of the European Union /
Publicado: (2005)

Adverse reactions following COVID-19 vaccine among healthcare professionals working in Ethiopia: a facility-based cross-sectional study
por: Asefa, Adisu, et al.
Publicado: (2023)

A review of China’s compensation program for adverse reactions following immunization
por: Yingxiong, Wu
Publicado: (2023)

Residential mobility predicts COVID-19 and seasonal flu vaccination behaviors in the United States
por: Zhang, Ning, et al.
Publicado: (2023)

The Companion Pandemic to COVID-19: The Use of Informal Practices to Access Public Healthcare Services in the European Union
por: Horodnic, Adrian V., et al.
Publicado: (2022)

Vaccine hesitancy and the willingness to recommend the COVID-19 vaccine to children in a rural country on the United States-Mexico border
por: Darisi, Raghu D., et al.
Publicado: (2023)

The knowledge, attitude and behaviours of nurses about pharmacovigilance, adverse drug reaction and adverse event reporting in a state hospital
por: Vural, Fisun, et al.
Publicado: (2015)

The State of Public Health Education and Science During and After the Fall of the Soviet Union: Achievements, Remaining Challenges, and Future Priorities
por: Gotsadze, George, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a7hc9qhod78eg64l6vct6uugk1